JavaScript is disabled. Please enable to continue!

Mobile search icon
Early Development >> Our Services >> Bioanalytics

Early Development Bioanalytical services

Sidebar Image

Leader in bioanalytical services

The Eurofins network of companies is a global leader for clinical and nonclinical bioanalysis. We are one of the largest bioanalytical CROs in terms of global presence, capacity, scientific expertise, number of different tests available and number of clients.

Our three bioanalytical facilities are located in the Netherlands, France, Germany and in the US and operate more than 28 LC/MS/MS systems. At Eurofins' network of Global Central Laboratory companiesEurofins ADME Bioanalyses SAS and Eurofins BioPharma Product Testing Munich GmbH we offer a premium service with an outstanding consulting activity. Our global bioanalytical group can respond to all of the complex analytical challenges encountered during nonclinical and clinical drug development. During the past year we have developed more than 450 methods with standard compounds and proprietary New Chemical Entities. These methods were developed for both small molecules and biologics. We take the time to understand our clients' study requirements. Our commitment to deliver the best service and our deep understanding of bioanalytical testing is the foundation for an honest and successful partnership with our clients.

One contact person and global, standardized processes

All of our bioanalytical facilities have installed WATSON to assure a uniform standard for our processes. One of the many reasons our clients keep returning to our pharma services is that their projects are coordinated by a single contact person. We offer the flexibility of working with a small size company along with the stability and resources provided by a large harmonized organization. Our bioanalytical services include:

  • Method Development & Validation according to FDA, May 2001 guidelines
  • DMPK Expertise Including Study Design, Sample & PK Analysis, and Report Preparation
  • Toxicokinetic
  • Extensive Sample Extraction Experience
  • Broad Range of Separation Techniques
  • Experience with Nearly 50 Types of Matrix
  • Drug Residue Analysis by LC-MS-MS
  • GLP analysis for Nonclinical or Clinical Samples
  • Metabolite Identification
  • Dose Formulation Analysis
  • Analysis Down to Picogram Levels
  • Integrated Therapeutic Drug Monitoring in clinical trials

Highest Standards of Quality

Eurofins companies use the same standardized methods, SOPs and bioanalytical experts to guarantee our clients the highest level of quality throughout the world. We are committed to the highest quality services and deliver accurate and timely results. Our laboratories are compliant to the following quality standards: ISO 15189 -  ISO/IEC 17025 - OECD Principles of Good Laboratory Practice (OECD GLP), and Good Clinical Practice (GCP).

Eurofins ADME Bioanalyses have been successfully inspected by FDA in July 2009.

For further information, please contact us: pharma@eurofins.com